Butera Andrea, Gallo Simone, Pascadopoli Maurizio, Maiorani Carolina, Milone Antonella, Alovisi Mario, Scribante Andrea
Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Microorganisms. 2022 Feb 1;10(2):337. doi: 10.3390/microorganisms10020337.
Periodontal disease represents a progressive destruction of tooth-supporting tissues. Recently, paraprobiotics are regarded as an adjunctive therapy to the non-surgical Scaling-and-Root-Planing (SRP). The aim of this study is to evaluate the efficacy of two new formulations of paraprobiotics, a toothpaste and a mouthwash, respectively, for the domiciliary hygiene. A total of 40 patients were randomly assigned to the following domiciliary treatments: Group 1 (SRP + Curasept Intensive Treatment 0.2% chlorhexidine) (control) and Group 2 (SRP + Biorepair Peribioma toothpaste + Biorepair Peribioma Mousse mouthwash) (trial). At baseline (T) and after 3 and 6 months (T-T), periodontal clinical (Bleeding on Probing, Probing Pocket Depth, Clinical Attachment Loss, Bleeding Score, Sulcus Bleeding Index, Plaque Index, Approximal Plaque Index, Adherent Gingiva, Gingival Recession, and Pathological Sites) and microbiological parameters (Pathological Bacteria, Saprophytic Bacteria, Enlarged Red Complex, Red Complex, Orange Complex, and counts of , , , , , and ). The use of the experimental products resulted in a significant reduction of most of the clinical indices assessed, which occurred at a major degree with respect to the conventional chlorhexidine considered as control. Additionally, after 6 months of use, the abovementioned products significantly decreased the percentage of pathological bacteria and the counts of those bacteria constituting the "Red Complex", more related to the periodontal disease. Accordingly, the paraprobiotics-based products tested in this study seem to represent a valid support to SRP with a benefit on both clinical indices and on specific periodontopathogens.
牙周病表现为牙齿支持组织的渐进性破坏。最近,副益生菌被视为非手术龈上洁治和根面平整(SRP)的辅助治疗方法。本研究的目的是评估两种新型副益生菌制剂(分别为牙膏和漱口水)用于家庭口腔卫生的疗效。总共40名患者被随机分配到以下家庭治疗组:第1组(SRP + 0.2%洗必泰Curasept强化治疗)(对照组)和第2组(SRP + Biorepair Peribioma牙膏 + Biorepair Peribioma慕斯漱口水)(试验组)。在基线(T)以及3个月和6个月后(T-T),记录牙周临床参数(探诊出血、探诊袋深度、临床附着丧失、出血评分、龈沟出血指数、菌斑指数、邻面菌斑指数、附着龈、牙龈退缩和病理部位)和微生物学参数(病原菌、腐生菌、扩大的红色复合体、红色复合体、橙色复合体以及 、 、 、 、 和 的计数)。使用实验产品导致大多数评估的临床指标显著降低,与作为对照的传统洗必泰相比,降低程度更大。此外,使用6个月后,上述产品显著降低了病原菌的百分比以及构成“红色复合体”的细菌数量,这些细菌与牙周病的关系更为密切。因此,本研究中测试的基于副益生菌的产品似乎是对SRP的有效支持,对临床指标和特定牙周病原菌均有益处。